Mol PGM - Search Results

1

Precision medicine in regulatory decision making: Biomarkers used for patient selection in European Public Assessment Reports from 2018 to 2020.

Bakker E, Starokozhko V, Kraaijvanger JWM, Heerspink HJL, Mol PGM. Bakker E, et al. Among authors: mol pgm. Clin Transl Sci. 2023 Nov;16(11):2394-2412. doi: 10.1111/cts.13641. Epub 2023 Oct 18. Clin Transl Sci. 2023. PMID: 37853917 Free PMC article.

2

Improving compliance with hospital antibiotic guidelines: a time-series intervention analysis.

Mol PG, Wieringa JE, Nannanpanday PV, Gans RO, Degener JE, Laseur M, Haaijer-Ruskamp FM. Mol PG, et al. J Antimicrob Chemother. 2005 Apr;55(4):550-7. doi: 10.1093/jac/dki037. Epub 2005 Feb 22. J Antimicrob Chemother. 2005. PMID: 15728141 Free article.

3

The influence that electronic prescribing has on medication errors and preventable adverse drug events: an interrupted time-series study.

van Doormaal JE, van den Bemt PM, Zaal RJ, Egberts AC, Lenderink BW, Kosterink JG, Haaijer-Ruskamp FM, Mol PG. van Doormaal JE, et al. J Am Med Inform Assoc. 2009 Nov-Dec;16(6):816-25. doi: 10.1197/jamia.M3099. Epub 2009 Aug 28. J Am Med Inform Assoc. 2009. PMID: 19717798 Free PMC article. Clinical Trial.

4

Comparison of potential risk factors for medication errors with and without patient harm.

Zaal RJ, van Doormaal JE, Lenderink AW, Mol PG, Kosterink JG, Egberts TC, Haaijer-Ruskamp FM, van den Bemt PM. Zaal RJ, et al. Pharmacoepidemiol Drug Saf. 2010 Aug;19(8):825-33. doi: 10.1002/pds.1977. Pharmacoepidemiol Drug Saf. 2010. PMID: 20681001

5

Anticoagulant medication errors in hospitals and primary care: a cross-sectional study.

Dreijer AR, Diepstraten J, Bukkems VE, Mol PGM, Leebeek FWG, Kruip MJHA, van den Bemt PMLA. Dreijer AR, et al. Among authors: mol pgm. Int J Qual Health Care. 2019 Jun 1;31(5):346-352. doi: 10.1093/intqhc/mzy177. Int J Qual Health Care. 2019. PMID: 30165484

6

[Interaction between clopidogrel and proton pump inhibitors].

Harmsze AM, de Boer A, Boot H, Deneer VH, Heringa M, Mol PG, Schalekamp T, Verduijn MM, Verheugt FW, le Comte M. Harmsze AM, et al. Ned Tijdschr Geneeskd. 2011;155(28):A2442. Ned Tijdschr Geneeskd. 2011. PMID: 21771377 Review. Dutch.

7

Empirical management of community-acquired pneumonia: impact of concurrent A/H1N1 influenza pandemic on guideline implementation.

Cortoos PJ, Gilissen C, Mol PG, Van den Bossche F, Simoens S, Willems L, Leenaers H, Vandorpe L, Peetermans WE, Laekeman G. Cortoos PJ, et al. J Antimicrob Chemother. 2011 Dec;66(12):2864-71. doi: 10.1093/jac/dkr366. Epub 2011 Sep 15. J Antimicrob Chemother. 2011. PMID: 21926079

8

Comparison of methods for identifying patients at risk of medication-related harm.

van Doormaal JE, Rommers MK, Kosterink JG, Teepe-Twiss IM, Haaijer-Ruskamp FM, Mol PG. van Doormaal JE, et al. Qual Saf Health Care. 2010 Dec;19(6):e26. doi: 10.1136/qshc.2009.033324. Epub 2010 Jun 27. Qual Saf Health Care. 2010. PMID: 20584702

9

The ISoP CommSIG for Improving Medicinal Product Risk Communication: A New Special Interest Group of the International Society of Pharmacovigilance.

Bahri P, Dodoo AN, Edwards BD, Edwards IR, Fermont I, Hagemann U, Hartigan-Go K, Hugman B, Mol PG. Bahri P, et al. Drug Saf. 2015 Jul;38(7):621-7. doi: 10.1007/s40264-015-0301-0. Drug Saf. 2015. PMID: 26032946 No abstract available.

10

Communication in drug safety: a report from an interactive debate held at the 10th annual meeting of the international society of pharmacovigilance (ISoP), 2010.

Bahri P, Mol PG, Théophile H, Edwards IR, Hugman BP. Bahri P, et al. Drug Saf. 2011 Oct 1;34(10):881-2. doi: 10.2165/11594430-000000000-00000. Drug Saf. 2011. PMID: 21879782 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

110 results

Search Page

Filters